Skip to main content
Clinical Trials/NCT04746261
NCT04746261
Recruiting
Not Applicable

A Randomized Clinical Study of "Attempted Suicide Short Intervention Program" in Swedish Healthcare - ASSIP

Region Skane2 sites in 1 country460 target enrollmentOctober 15, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Suicide, Attempted
Sponsor
Region Skane
Enrollment
460
Locations
2
Primary Endpoint
Number of suicide attempts up to 3 months after inclusion
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

This is a randomized study of ASSIP as a treatment for patients who have recently made a suicide attempt. Six psychiatric clinics from four regions in Sweden are included. Together 460 patients will be recruited. Patients will be randomized to ASSIP as a supplement to treatment as usual or to treatment as usual only.

The overall aim of the study is to evaluate whether ASSIP, a short-term clinical intervention, can prevent future suicidal behavior in people who have attempted suicide better than just conventional treatment. The project also investigates whether there are any specific factors that may be related to ASSIP's potential effectiveness and whether ASSIP has health economic benefits.

Only patients who give their written consent will be included in the study. Those who meet the inclusion and no exclusion criteria at screening / visit 1 undergo an assessment according to an interview protocol, self-assessment form, and self-assessment scales. Thereafter, the patient is randomized via an electronic system to either ASSIP plus standard treatment or only standard treatment. All patients, regardless of which treatment they are randomized to, will be followed up for two years with a telephone interview and self-assessment scales month 3, 12 and 24. Data from medical records and registers will also be collected.

Detailed Description

Purpose and aims: The overall purpose of this project is to evaluate ASSIP for the prevention of future suicidal behavior in persons who attempt suicide. The specific goals are a) to examine the effectiveness of Attempted Suicide Short Intervention Program (ASSIP) in reducing new suicide attempts in Swedish healthcare, b) to identify factors associated with the effectiveness of ASSIP, c) to construct a cost-effectiveness model of ASSIP. Background: According to a consensus position paper from the evidence-based national suicide prevention task force in Europe, health care approaches with high evidence include treatment of depression and ensuring chain of care. These strategies are in line with Swedish guidelines. However, several recent international studies suggest that interventions specifically targeted to prevent suicide attempts may be more successful and that brief psychological interventions are of interest . One promising brief psychotherapeutic intervention to prevent new suicide attempts in suicide attempters is ASSIP . An RCT from Switzerland that included 120 patients showed an 80% risk reduction for new suicide attempt within two years, when ASSIP was added on to treatment as usual (TAU) compared to TAU alone. Study design: This is an evaluator-blinded, multicenter randomized controlled trial (RCT). The patients will be examined with a structured interview and self-rating scales at baseline (first visit), and structured telephone interviews, self-rating scales and medical record screening at 3 months, 12 months and 24 months follow up. Completed suicides will be detected through the Cause of Death Register. The study will also collect information from the National Board of Health and Welfare (NBHW), National Prescribed Drugs Register (NPDR), Longitudinal integrated database for health insurance and labour market studies (LISA) and the Swedish Social Insurance Agency (Försäkringskassan). Randomization: After the first visit, the patients will be randomized to ASSIP+ TAU or TAU only, using stratified randomization according to clinical site. The randomization will be performed through REDCAP, a web-based application for electronic data collection in research studies. Expected site differences: To map the variation of TAU with site, age, gender, ICD diagnoses and previous suicide attempts, health care contacts and treatments a TAU check list will be used.

Registry
clinicaltrials.gov
Start Date
October 15, 2020
End Date
September 30, 2026
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥18 years.
  • Signed informed consent to participate in the study.
  • Contact with psychiatric health care after a suicide attempt within 3 months before the baseline visit
  • Booked meeting or visit in psychiatry or primary care after visit 1

Exclusion Criteria

  • Psychotic illness with current delusions, hallucinations or other negative symptoms that may affect the therapy.
  • Known emotionally unstable personality disorder (ICD 10) noted in the medical record
  • Inability to undergo therapy without an interpreter
  • Mental retardation, dementia, or other circumstances that make it difficult to understand the meaning of participating in the study and giving informed consent.

Outcomes

Primary Outcomes

Number of suicide attempts up to 3 months after inclusion

Time Frame: 3 months after inclusion in study

Telephone follow up at 3 months after inclusion. Medical records data. Register data.

Incremental Cost-Effectiveness Ratio( ICER).

Time Frame: 24 months after inclusion

RCT outcomes put into perspective using a health-economic model with a life-time horizon, evidence from literature and complementary register data.

Number of suicide attempts up to 24 months after inclusion

Time Frame: 24 months after inclusion in study

Repeated telephone follow up at 3, 12 and 24 months after inclusion. Medical records data. Register data

Number of suicide attempts up to 12 months after inclusion

Time Frame: 12 months after inclusion in study

Repeated telephone follow up at 3, 12 after inclusion. Medical records data. Register data.

Secondary Outcomes

  • Changes in Quality of life(24 months)
  • Number of suicidal thoughts/plans within 3 months after inclusion(3 months after inclusion in study)
  • Periods of employment, unemployment, education, military service or pension(24 months)
  • Number of days with sickness and disability benefits(24 months)
  • Health care contacts and treatments(24 months after inclusion)
  • Number of suicidal thoughts/plans within 24 months after inclusion(24 months after inclusion in study)
  • Number of suicidal thoughts/plans within 12 months after inclusion(12 months after inclusion in study)
  • Amount of income from employment, social insurance, student aid, pension and unemployment benefits.(24 months)

Study Sites (2)

Loading locations...

Similar Trials